This population-based study characterize rates of hematuria-related complications among patients taking antithrombotic medications.
This study uses National Electronic Injury Surveillance System–Cooperative Adverse Drug Event Surveillance data to characterize emergency department visits for adverse drug events in the United States in 2013-2014 and to describe changes in emergency department visits for adverse drug events since 2005-2006
This Viewpoint discusses optimal dosing recommendations for new anticoagulant agents.
This retrospective cohort study in Germany reports on analyses of the treatment of oral anticoagulation–associated intracerebral hemorrhage and its association with rates of hematoma enlargement, ischemic and hemorrhagic events with or without resumption of oral anticoagulation, and long-term functional outcome.
This analysis of data from Danish administrative registries reports that among patients receiving antithrombotic therapy after myocardial infarction, use of nonsteroidal anti-inflammatory drugs was associated with increased risk of bleeding and thrombotic events.
This Viewpoint discusses potental hazards related to the concomitant use of nonsteroidal anti-inflammatory drugs and antithrombotic therapy after myocardial infarction.
You currently have no searches saved.